Cargando…
Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient
Acquired von Willebrand Syndrome (AVWS) is a rare coagulation disorder which can be associated with IgM paraproteinaemia. Recently, recombinant von Willebrand factor (rVWF) has become available for the treatment of bleedings in patients with inherited von Willebrand disease, but experience in patien...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501758/ https://www.ncbi.nlm.nih.gov/pubmed/35086107 http://dx.doi.org/10.1159/000522236 |
_version_ | 1784795549178789888 |
---|---|
author | Höpting, Matthias Budde, Ulrich Tiede, Andreas Grube, Matthias Hahn, Joachim Herr, Wolfgang Heimerl, Susanne Hart, Christina |
author_facet | Höpting, Matthias Budde, Ulrich Tiede, Andreas Grube, Matthias Hahn, Joachim Herr, Wolfgang Heimerl, Susanne Hart, Christina |
author_sort | Höpting, Matthias |
collection | PubMed |
description | Acquired von Willebrand Syndrome (AVWS) is a rare coagulation disorder which can be associated with IgM paraproteinaemia. Recently, recombinant von Willebrand factor (rVWF) has become available for the treatment of bleedings in patients with inherited von Willebrand disease, but experience in patients with AVWS is limited. We report on 2 patients with AVWS with underlying IgM paraproteinaemia with distinct underlying pathomechanisms. In 1 patient, the paraprotein built unspecific complexes with von Willebrand factor (VWF). In the other patient, we were able to detect an IgM antibody against VWF. Bleeding in this patient was successfully treated with rVWF. To our knowledge, this is the first report about the successful use of rVWF in a patient with AVWS with the detection of a VWF-specific antibody. |
format | Online Article Text |
id | pubmed-9501758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-95017582022-09-24 Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient Höpting, Matthias Budde, Ulrich Tiede, Andreas Grube, Matthias Hahn, Joachim Herr, Wolfgang Heimerl, Susanne Hart, Christina Acta Haematol Case Report Acquired von Willebrand Syndrome (AVWS) is a rare coagulation disorder which can be associated with IgM paraproteinaemia. Recently, recombinant von Willebrand factor (rVWF) has become available for the treatment of bleedings in patients with inherited von Willebrand disease, but experience in patients with AVWS is limited. We report on 2 patients with AVWS with underlying IgM paraproteinaemia with distinct underlying pathomechanisms. In 1 patient, the paraprotein built unspecific complexes with von Willebrand factor (VWF). In the other patient, we were able to detect an IgM antibody against VWF. Bleeding in this patient was successfully treated with rVWF. To our knowledge, this is the first report about the successful use of rVWF in a patient with AVWS with the detection of a VWF-specific antibody. S. Karger AG 2022-07 2022-01-27 /pmc/articles/PMC9501758/ /pubmed/35086107 http://dx.doi.org/10.1159/000522236 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by/4.0/This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
spellingShingle | Case Report Höpting, Matthias Budde, Ulrich Tiede, Andreas Grube, Matthias Hahn, Joachim Herr, Wolfgang Heimerl, Susanne Hart, Christina Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient |
title | Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient |
title_full | Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient |
title_fullStr | Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient |
title_full_unstemmed | Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient |
title_short | Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient |
title_sort | distinct mechanisms of igm antibody-mediated acquired von willebrand syndrome and successful treatment with recombinant von willebrand factor in one patient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501758/ https://www.ncbi.nlm.nih.gov/pubmed/35086107 http://dx.doi.org/10.1159/000522236 |
work_keys_str_mv | AT hoptingmatthias distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient AT buddeulrich distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient AT tiedeandreas distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient AT grubematthias distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient AT hahnjoachim distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient AT herrwolfgang distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient AT heimerlsusanne distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient AT hartchristina distinctmechanismsofigmantibodymediatedacquiredvonwillebrandsyndromeandsuccessfultreatmentwithrecombinantvonwillebrandfactorinonepatient |